Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EN6203 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | ER8727 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | FT8757 | IM / AR |
PFIZER #1 3/13/2021 PFIZER #2 4/5/2021 PFIZER #3 12/29/2021 DEVELOPED WORSENED ANXIETY DEPRESSION BIPOLAR SYMPTOMS REQUIRING VENLAFAXINE AND LAMICTAL. DEVELOPED DYSFUNCTIONAL UTERINE BLEEDING AND POST EXERTIONAL MALAISE. DIAGNOSIS POST VACCINE INJURY SYNDROME.
LEFT LEG OSTEOSARCOMA AGE 11 TREATED WITH SURGERY AND CHEMOTHERAPY
PENICILLIN, MORPHINE, DILAUDID
LABS ECG, ECHOCARDIOGRAPHY, CARDIAC MRI, SPECIALIZED MOLECULAR LABORATORIES PEFORMED AT THE LAB. spike protein in plasma 111.79 +/- 2.28 fg/ml spike protein in PBMC Negative spike protein in exosomes 27.62 +/- 3.65 fg per 1ml Plasma Vaccine mRNA in PBMC positive for 2 spike protein sequences (3rd sequence unsure) Vaccine mRNA in exosomes positive for 2 spike protein sequences (3rd sequence unsure) Plasmid-DNA in PBMC positive for ori and SV40 negative for spike protein Plasmid-DNA in exosomes All negative SARS-CoV-2 Spike Ab Dilution 14215 9/10/2024 14740 08/19/2024